If the FDA *has* been keeping tabs on Leronlimab and has recently decided it warrants an EUA, maybe it waited until the trial filled to ensure that blinded trial data eventually comes and they can give full approval...

Ergo EUA forthcoming?

Hey, a boy can dream.

I’ll settle for a completed enrollment PR tomorrow.